Prospective medicine: the role for genomics in personalized health planning
- 1 January 2004
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 5 (1) , 1-8
- https://doi.org/10.1517/phgs.5.1.1.25685
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Welcome to the Genomic EraNew England Journal of Medicine, 2003
- Genomic profiling to promote a healthy lifestyle: not ready for prime timeNature Genetics, 2003
- Personalized Health PlanningScience, 2003
- Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor GeneNew England Journal of Medicine, 2003
- Binge Eating as a Major Phenotype of Melanocortin 4 Receptor Gene MutationsNew England Journal of Medicine, 2003
- Design and Pharmacology of N-[(3R)-1,2,3,4-Tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a Potent, Selective, Melanocortin Subtype-4 Receptor AgonistJournal of Medicinal Chemistry, 2002
- Health Spending Projections For 2001–2011: The Latest OutlookHealth Affairs, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Genetic risk and behavioural changeBMJ, 2001
- Population Screening in Hereditary HemochromatosisAnnual Review of Public Health, 2000